Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00142844 · ClinicalTrials.gov registry record · Phase 2
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
A Phase 2 study of Alcoholism and Cocaine-Related Disorders, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT00142844: Completed Phase 2 study of Alcoholism and Cocaine-Related Disorders, sponsored by University of Pennsylvania.
NCT00142844 is a Phase 2 study of Alcoholism and Cocaine-Related Disorders that has completed, run by University of Pennsylvania. The registered enrollment target is 208 participants, below the 372-participant average among 65 other Alcoholism trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00142844, a Phase 2 study of Alcoholism and Cocaine-Related Disorders, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
Many cocaine dependent individuals are also dependent on alcohol. Such individuals respond poorly to existing treatments and have received little research attention in the past. The purpose of this study is to determine whether the combination of naltrexone and disulfiram is useful in decreasing alcohol use and cravings in people diagnosed with both cocaine and alcohol dependence.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Naltrexone
- DRUG Disulfiram
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 1999-09 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
What the finished NCT00142844 record still lists
NCT00142844 is an interventional study that assigns participants to a tested intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 372-participant average among 65 other Alcoholism trials with a reported enrollment target (44% lower).
The record links to 3 conditions, with Alcoholism appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00142844 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00142844 about?
NCT00142844 is a clinical study titled "Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1". Many cocaine dependent individuals are also dependent on alcohol. Such individuals respond poorly to existing treatments and have received little research attention in the past. The purpose of this study is to determine whether the combination of naltrexone and disulfiram is useful in decreasing alc...
What is the current status of trial NCT00142844?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 208 participants. The study started on 1999-09. Estimated completion is 2008-01.
What conditions does trial NCT00142844 study?
This clinical trial studies the following conditions: Alcoholism, Cocaine-Related Disorders, Alcohol-Related Disorders.
What interventions are being tested in trial NCT00142844?
The interventions under investigation include: Placebo (DRUG), Naltrexone (DRUG), Disulfiram (DRUG).
Who is sponsoring clinical trial NCT00142844?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00142844 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00142844's enrollment target sits among peer trials
208 16th of 65 higher than 50 of 65 other Alcoholism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcoholism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketamine Alcohol (in Treatment-Resistant Depression)
RECRUITING · Phase 2
-
Ibudilast for Treating Alcohol Use Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Gabapentin Treatment of Alcohol Dependence
COMPLETED · Phase 2
-
A Study of LY2940094 in Participants With Alcohol Dependency
COMPLETED · Phase 2
-
Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients
COMPLETED · Phase 2
-
Drug Therapy for Alcohol Dependence in Alaska Natives (Naltrexone/Sertraline)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia